AASM Membership Sections Newsletter Issue #2
10
American Academy
of Sleep Medicine
References
Bailes, S., Baltzan, M., Grad, R., Pavilanis, A., Rizzo, D., Creti, L., et al. (2012).
The sleep symptoms checklist provides distinctive profiles for sleep apnea,
chronic insomnia, and no sleep disorder for primary care patients.
Sleep,
35
(
Abstract supplement).
Basta, M., Vgontzas, A., Fernandez-Mendoza, J., & Singareddy, R. (2012). Is
there a link between sleep apnea and chronic insomnia?
Sleep, 35
(
Abstract
supplement).
Berkowitz Sturgis, E., Jackson, N., Gehrman, P., Grandner, M., & Perlis, M.
(2012
a). Do patients with insomnia get less sleep than subjects without
insomnia?
Sleep, 35
(
Abstract supplement ).
Berkowitz Sturgis, E., Jackson, N., Gehrman, P., Grandner, M., & Perlis, M.
(2012
b). Insomnia symptoms and problematic sleep duration.
Sleep, 35
(
Ab-
stract supplement).
Bremer, E., Beqiri, E., Ramirez, A., Grandner, M., Jackson, N., Gehrman, P., et
al. (2012). What events serve as precipitating factors for chronic insomnia
and are some events associated with greater illness severity?
Sleep, 35
(
Ab-
stract supplement).
Budhiraja, R., Parthasarathy, S., P, B., Habib, M., Wendel, C., & Quan, S. (2012).
Insomnia in patients with COPD.
Sleep, 35
(3), 369-375.
Chang, C., Yang, Y., Lin, S., Su, J., Cheng, C., & Lin, L. (2012). Risk of insomnia
attributable to β-blockers in elderly patients with newly diagnosed hyperten-
sion.
Drug Metab Pharmacokinet, ahead of print
.
Comai, S., Ochoa-Sanchez, R., Dominguez-Lopez, S., Spadoni, G., Rivara, S.,
Bedini, A., et al. (2012). A novel selective melatonin MT2 receptor ligand for
the treatment of insomnia.
Sleep, 35
(
Abstract supplement ).
de Zambotti, M., Covassin, N., Sarlo, M., De Min, G., Trinder, J., & Stegagno,
L. (2012). Nighttime cardiac sympathetic hyper-activation in young primary
insomniacs.
Clin Auton Res, Ahead of print
.
Dominguez-Rodriguez, A. (2012). Melatonin in cardiovascular disease.
Expert
Opin Investig Drugs, 21
(11), 1593-1596.
Edinger, J., Means, M., & Krystal, A. (2012). Does hyperarousal increase daytime
error proneness among insomnia sufferers.
Sleep, 35
(
Abstract supplement).
Fernandez-Mendoza, J., Vgontzas, A., Liao, D., Shaffer, M., Vela-Bueno, A.,
Basta, M., et al. (2012). Insomnia with objective short sleep duration and
incident hypertension: the Penn state cohort.
Hypertension, 60
(4), 929-935.
Garb, L., Bootzin, R., Dawson, S., Cousins, J., Fridel, K., Sidani, S., et al. (2012).
Cognitive behavioral treatment for insomnia improves sleep efficiency and
ISI in insomnia co-morbid with sleep apnea or periodic limb movements.
Sleep, 35
(
Abstract supplement).
Gulley, C., Becker, K., Ho, S., Chang, J., Petrilla, J., Kim, J., et al. (2012). Ef-
fectiveness of a single-session cognitive behavioral therapy program in a large
group setting for insomnia.
Sleep, 35
(
Abstract supplement).
Hantsoo, L., Khou, C., & Ong, J. (2012). Predictors of pre-sleep arousal: bad
thoughts or negative feelings?
Sleep, 35
(
Abstract supplement).
Harris, A., Carney, C. E., & Zalai, D. (2012). The unique contribution of
insomnia-based rumination in those with depression and insomnia.
Sleep,
35
(
Abstract supplement).
Herring, W., Snyder, E., Paradis, E., Liu, M., Snavely, D., Roth, T., et al. (2012).
Long term safety and efficacy of suvorexant in patients with primary insom-
nia.
Sleep, 35
(
Abstract supplement).
Ivgy-May, N., Amari, N., Pathiraja, K., Rowe, E., & Roth, T. (2012). Efficacy
and safety of esmirtazapine in a six-week sleep laboratory in patients with
primary insomnia.
Sleep, 35
(
Abstract supplement).
Ivgy-May, N., Roth, T., Amari, N., Pathiraja, K., & Walsh, J. (2012). Efficacy and
safety of esmirtazepine in non-elderly adult patients with primary insomnia:
A 2-week outpatient trial.
Sleep, 35
.
Laugsand, L., Vatten, L., Bjørngaard, J., Hveem, K., & Janszky, I. (2012). In-
somnia and high-sensitivity C-reactive protein: the HUNT study, Norway.
Psychosom Med, 74
(5), 543-553.
Mansoor, E., Koshorek, J., Roth, T., Seto, J., & Drake, C. (2012). Hypertension
prevalence and severity in relation to insomnia symptom pattern.
Sleep,
35
(
Abstract supplement).
Miksiewicz, T., Fernandez-Mendoza, J., Vgontzas, A., Shaffer, M., Liao, D., &
Bixler, E. (2012). Insomnia and objective short sleep duration predict the in-
cidence of diabetes: A longitudinal population based study.
Sleep, 35
(
Abstract
supplement).
Nakazaki, C., Noda, A., Koike, Y., Yamada, S., Murohara, T., & Ozaki, N. (2012).
Association of Insomnia and Short Sleep Duration With Atherosclerosis Risk
in the Elderly.
Am J Hypertens, Ahead of print
.
Nowakowski, S., Dowdle, C., Suh, S., Siebern, A., & Manber, R. (2012). Ex-
amination of cognitive behavioral therapy for insomnia in perimenopausal
women.
Sleep, 35
(
Abstract supplement ).
Pachman, D., Barton, D., Swetz, K., & Loprinzi, C. (2012). Troublesome Symp-
toms in Cancer Survivors: Fatigue, Insomnia, Neuropathy, and Pain.
J Clin
Oncol, Ahead of print
.
Parsons, E., Kross, E., Caldwell, E., Kapur, V., McCurry, S., Vitiello, M., et al.
(2012).
Post-discharge insomnia symptoms are associated with quality of life
impairment among survivors of acute lung injury.
Sleep Med, 13
(8), 1106-
1109.
Pillar, G., & Daniel, I. (2012). Objective insomnia but not sleep state mispercep-
tion is associated with overnight deterioration of endothelial function.
Sleep,
35
(
Abstract supplement).
Redeker, N., Alexander, N., Alexander, I., Heany, B., Mehta, S., Knechel, N., et al.
(2012).
Perceptions of nurse practitioners about assessment and treatment of
insomnia in primary care settings.
Sleep, 35
(
Abstract supplement).
Redeker, N., Andrews, L., Cline, J., Jacoby, D., Jeon, S., Paceill, J., et al. (2012).
Cognitive behavioral therapy for insomnia in stable heart failure: feasibility,
acceptability, and preliminary efficacy.
Sleep, 35
(
Abstract supplement ).
Roehrs, T., Randall, S., & Roth, T. (2012a). Chronic hypnotic self-administration
and hyperarousal in insomnia.
Sleep, 35
(
Abstract supplement).
Roehrs, T., Randall, S., & Roth, T. (2012b). Daytime urinary norepinephrine
levels in hyperaroused insomniacs.
Sleep, 35
(
Abstract supplement).
Sabanayagam, C., Shankar, A., Buchwald, D., & Goins, R. (2011). Insomnia
symptoms and cardiovascular disease among older American Indians: the
Native Elder Care Study.
J Environ Public Health, 964617
.
Sanchez-Ortuno, M., Carney, C., Wyatt, J., & Edinger, J. (2012). Arousal phe-
notypes in insomnia: A study of their sleep and daytime correlates.
Sleep,
35
(
Abstract supplement).
Santos, B., Lindauer, A., Baleeiro, T., Gropper, S., D’Aniello, F., Horoszok, L., et
al. (2012). Pharmacokinetics following single and multiple administration of
the novel non-benzodiazepine hypnotic drug lorediplon to health volunteers.
Sleep, 35
.
Sofi, F., Cesari, F., Casini, A., Macchi, C., Abbate, R., & Gensini, G. (2012). In-
somnia and risk of cardiovascular disease: a meta-analysis.
Eur J Prev Cardiol,
Ahead of print
.
Tegeler, C., Kumar, S., Conklin, D., Turner, D., Tegeler, C., McCall, V., et al.
(2012).
A new method of dynamic, relational, electroencephalic auditory
feedback for primary insomnia.
Sleep, 35
(
Abstract supplement).
Vermeeren, A., Vuurman, E., Bautmans, A., Li, X., Vets, E., Lewis, N., et al.
(2012).
Suvorexant, a dual orexin receptor antagonist, does not impair next
day driving performance in healthy elderly subjects.
Sleep, 35
(
Abstract
supplement).
Zottola, K., Germain, A., Buysse, D., Begley, A., & Hall, M. (2012). The pre-
sleep experience questionnaire: measuring hyperarousal and its short-term
relationship with sleep in individuals with insomnia and good sleepers.
Sleep,
35
(
Abstract supplement).